Many patients with end-stage heart disease die because of the scarcity of donor hearts. A
total artificial heart (TAH), an implantable machine that replaces the heart, has so far been …

Heart failure (HF) is common in adult congenital heart disease (ACHD) patients; however,
use of continuous-flow ventricular assist devices (CF-VADs) remains rare. We reviewed …

Objective: Total artificial hearts (TAH) serve as a temporary treatment for severe biventricular
heart failure. The limited durability and complication rates of current devices hamper long …

Rotary blood pumps (RBPs) operating at a constant speed generate non-physiologic blood
pressure and flow rate, which can cause endothelial dysfunction, leading to adverse clinical …

Background Heart failure is a growing health problem worldwide. Due to the lack of donor
hearts there is a need for alternative therapies, such as total artificial hearts (TAHs). The aim …

Widespread use of heart transplantation is limited by the scarcity of donor organs. Total
artificial heart (TAH) development has been pursued to address this shortage, especially to …

Purpose Artificial heart pumps are widely used for medical auxiliary blood supply, but the
existing technology has some defects. To solve the problems of traditional artificial heart …

Left ventricular assist devices (LVADs) have been used as a bridge to transplantation or as
destination therapy to treat patients with heart failure (HF). The inability of control strategy to …

In order to enable continuous-flow left ventricular assist device (CFLVAD) to adjust pump
speed adaptively in response to changes in ventricular load, we developed a multi-objective …

Earlier left ventricular assist devices (LVADs) were volume displacement pumps (VDPs) that
delivered pulsatile flow. However, due to improved survival rates of rotary blood pumps …